Yes. Compounded tirzepatide expires, and its beyond-use date is not interchangeable with branded pens or vials.
Short answer: follow the BUD and storage instructions from the pharmacy that made the compounded tirzepatide. Do not use it after the BUD, after improper storage, or if it looks cloudy, discolored, or contaminated. Two numbers do most of the work: the BUD printed on your label, and — for a multiple-dose vial — 28 days from the first puncture, whichever comes first. Both are explained with the underlying USP limits below.
What to Check
| Check | Why |
|---|---|
| BUD | Main use-by date for the compound |
| Storage range | Refrigeration and excursion rules |
| Puncture date | Multi-dose sterility concern |
| Appearance | Cloudy or particles means stop |
| Pharmacy source | Quality and instructions matter |
How Long Compounded Tirzepatide Actually Lasts
"Expires" is the wrong word for a compounded drug, and the difference is not pedantic. A manufactured product carries an expiration date backed by the manufacturer's stability program. A compounded product carries a beyond-use date (BUD): the date, or hour and date, after which it must not be used, stored or transported, counted from the moment it was compounded.
For a state-licensed (503A) compounding pharmacy, those BUDs are not invented per order. They come from USP General Chapter <797>, which caps how long a compounded sterile preparation can be dated based on how it was made, whether it was sterility tested, and how it is stored. The 2023 revision replaced the old low/medium/high-risk levels with Category 1, 2 and 3 preparations. The caps in Tables 13 and 14 of that chapter are:
| How the preparation was made | Room temp | Refrigerated | Frozen |
|---|---|---|---|
| Category 1 (ISO 5 hood in an unclassified segregated area) | ≤ 12 hours | ≤ 24 hours | — |
| Category 2, aseptically processed, all sterile starting components, no sterility test | 4 days | 10 days | 45 days |
| Category 2, aseptically processed, one or more nonsterile starting components, no sterility test | 1 day | 4 days | 45 days |
| Category 2, aseptically processed, passed sterility testing | 30 days | 45 days | 60 days |
| Category 2, terminally sterilized, no sterility test | 14 days | 28 days | 45 days |
| Category 2, terminally sterilized, passed sterility testing | 45 days | 60 days | 90 days |
| Category 3, aseptically processed, sterility tested, meets all Category 3 requirements | 60 days | 90 days | 120 days |
| Category 3, terminally sterilized, sterility tested, meets all Category 3 requirements | 90 days | 120 days | 180 days |
Limits from USP General Chapter <797>. A pharmacy may assign a shorter BUD than the cap; it may not assign a longer one.
Read that table with your own vial in mind. Compounded peptide injectables are generally aseptically processed rather than terminally sterilized, which puts them in the middle rows. That is the whole reason a compounded tirzepatide vial is dated in days or weeks while a sealed Zepbound pen is dated in months: a pharmacy that does not sterility test every batch is capped low, one that does test can reach 45 days refrigerated, and only a pharmacy meeting the full Category 3 requirements can reach 90 days refrigerated. If you are still choosing a pharmacy, our guide to buying compounded tirzepatide covers what to check before you pay.
Two consequences worth acting on:
- A longer BUD is not a better product; it is a claim about the facility. If a vial arrives dated 90 days out, that pharmacy is asserting Category 3 compliance. You are allowed to ask them to confirm it.
- 503A and 503B are not the same rulebook. FDA-registered outsourcing facilities (503B) are subject to current good manufacturing practice requirements, while drugs compounded in a state-licensed pharmacy under section 503A are not. A 503B product's dating comes from its own stability data rather than from the <797> category caps. Either way, compounded drugs are not FDA-approved, and the agency does not verify their safety, effectiveness or quality before they are marketed.
The 28-Day Rule Most People Miss
The BUD is not the same thing as how long you may keep using a vial after you stick a needle in it. USP <797> is explicit: after a multiple-dose compounded preparation is first entered or punctured, it must not be used for longer than its assigned BUD or 28 days, whichever is shorter. USP's own worked example: a multiple-dose vial may carry a 60-day BUD and still has to be discarded no later than 28 days after first puncture.
So a compounded tirzepatide vial has two clocks running, and the earlier one wins:
| Clock | Starts | Ends |
|---|---|---|
| Beyond-use date | The moment the pharmacy compounded it | The BUD printed on the label |
| In-use time (multiple-dose vials) | The first needle stick | 28 days later, at the latest |
If your label says single-dose, there is no second clock — a single-dose container is not intended to be re-entered and stored across weeks. And a container whose closure system is no longer intact, such as a vial with the septum or metal ring removed, is treated as unstorable regardless of what the date says. If your label does not tell you which kind of vial you have, that is the question to ask the pharmacy first.
Compounded vs Branded: The Dating Rules Side by Side
Branded tirzepatide has published, fixed rules. This is the comparison people are actually making when they ask whether compounded tirzepatide expires:
| Product | Refrigerated | Room temperature | Discard when |
|---|---|---|---|
| Zepbound or Mounjaro single-dose pen / single-dose vial | 2°C to 8°C (36°F to 46°F) until the printed expiration date | Up to 30°C (86°F) for up to a total of 21 days | After a total of 21 days at room temperature |
| Zepbound or Mounjaro multi-dose vial or KwikPen, unopened | 2°C to 8°C until the printed expiration date | Up to 30°C, then throw away after 30 days | 30 days at room temperature, or the printed expiry |
| Zepbound or Mounjaro multi-dose vial or KwikPen, after first use | 2°C to 8°C, in the original carton | Up to 30°C | 30 days at room temperature, 30 days after first use, or after 4 weekly doses — whichever comes first, even if medicine is left |
| Compounded tirzepatide vial | Per the pharmacy's own storage instructions | Only if the pharmacy says so | The printed BUD, or 28 days after first puncture for a multiple-dose vial — whichever is shorter |
Neither product may be frozen, and neither should be used if it has been frozen. Both should be protected from heat and light and kept in the original carton or packaging.
The row that catches people out is the third one. Even a branded multi-dose vial that lives in the fridge its whole life is done 30 days after first use, or after four weekly doses. "There's medicine left in it" is not a reason to keep going, and that logic carries over to compounded vials with more force, not less.
Internal Reading Path
More from Middleway Nutrition on compounded tirzepatide storage and dosing:
Storage Decision Tree
For does compounded tirzepatide expire, the safest answer comes from the exact product label or the dispensing pharmacy. Branded pens, branded vials, compounded vials, and prefilled syringes can have different stability and sterility rules. Do not use a room-temperature rule from one product to justify using a different product.
Start with these questions: What product is it? Was it unopened, opened, or punctured? What was the highest likely temperature? How long was it out? Did it freeze? Does it look clear and particle-free? Is the expiration date or beyond-use date still valid? If any answer is uncertain, call the pharmacist.
| Situation | Safer next step |
|---|---|
| Hot car or direct sun | Call before use; heat exposure is high risk |
| Frozen product | Call; many peptide products should not be used after freezing |
| Cloudy or particles | Do not use until pharmacy reviews |
| Expired or past BUD | Replace rather than guessing |
| Compounded vial | Follow the pharmacy-specific BUD and storage instructions |
What to Say When You Call the Pharmacy
Use concrete details. Say the medication name, strength, dosage form, lot number if available, expiration or BUD, whether it was opened or punctured, how long it was out, the approximate temperature, and whether the appearance changed. Ask whether it should be used, discarded, replaced, or documented.
This matters because pharmacists can often make a better decision with specifics than with a general question like, 'Is it still good?'
Prevention for Travel and Weekly Routines
Store medication where temperature is stable, not in a car, checked bag, sunny window, freezer area, or bathroom. Use reminders for injection day, keep the box or pharmacy label until the medication is finished, and write the puncture or first-use date on compounded vials if the pharmacy recommends it. For travel, ask the pharmacy about insulated storage and what to do if the product is delayed or arrives warm.
Questions to Bring to the Prescriber or Pharmacist
- Does my current dose and timing match the official label or my prescription?
- Are my symptoms or concerns expected at this stage, or do they suggest changing the plan?
- Should I delay escalation, restart lower, hold steady, or be evaluated before continuing?
- Are any of my other medications increasing risk, especially insulin, sulfonylureas, blood pressure medication, diuretics, or drugs affected by delayed gastric emptying?
- What exact symptoms should make me call urgently or seek same-day care?
- If cost or supply interrupts therapy, what is the safest backup plan?
Bottom Line for Does Compounded Tirzepatide Expire?
The practical answer is rarely just one number, food list, or yes-or-no rule. For does compounded tirzepatide expire, the safest approach is to combine the direct answer with the variables that change it: product type, dose, timing, side effects, storage history, other medications, and the person's medical context. When those variables are unclear, the best next step is to ask the prescriber or pharmacist before acting.
Additional Scenarios Readers Commonly Compare
| Scenario | How to think about it |
|---|---|
| Symptoms started after a dose increase | Treat escalation as a likely contributor and ask whether to hold the dose longer |
| The plan changed because of supply | Confirm whether a restart or lower dose is safer after the gap |
| Advice online conflicts with the label | Use the label, pharmacy, and prescriber as the authority |
| The medication is compounded | Verify concentration, BUD, storage, sterility, and dose instructions directly with the pharmacy |
| The goal is maintenance | Prioritize sustainable intake, resistance training, monitoring, and follow-up |
More FAQ
How long is compounded tirzepatide good for?
There is no single number, because the BUD is set by the pharmacy that made it and is capped by how that preparation was made. Under USP <797>, an aseptically processed sterile preparation that has not been sterility tested is capped at 4 days refrigerated if any starting component was nonsterile, 10 days if all were sterile, 45 days if it passed sterility testing, and 90 days only under full Category 3 compliance. On top of that, a multiple-dose vial must be discarded no later than 28 days after the first puncture even if its BUD is longer. The date on your label is the answer for your vial; the table above is what constrains it.
What is the difference between an expiration date and a beyond-use date?
An expiration date comes from the manufacturer's stability testing on a specific commercial product and appears on FDA-approved drugs like Zepbound and Mounjaro. A beyond-use date is assigned by the compounder and counted from the moment of compounding, based on the <797> category limits, storage conditions and any supporting stability data. They are not interchangeable, and a compounded vial never inherits the branded product's expiry.
Can I use compounded tirzepatide past the beyond-use date if it was always refrigerated?
No. Continuous refrigeration is one of the assumptions built into the BUD, not a reason to extend it. The BUD already accounts for storage temperature — that is why the same preparation gets different limits at room temperature, refrigerated and frozen. Past the BUD, there is no data supporting either potency or sterility, and sterility is the half that can hurt you. Replace it.
Why do different websites give different answers?
Most differences come from assuming different products, concentrations, patient goals, dose histories, or risk tolerance. A chart or tip can be mathematically correct but still wrong for a specific prescription.
What information should I keep in my notes?
Keep the medication name, dose, date taken, pharmacy label, concentration if vial-based, side effects, food and fluid changes, weight trend, and any clinician instructions. This makes follow-up safer and more specific.
When is it better not to troubleshoot at home?
Do not troubleshoot at home when symptoms are severe, rapidly worsening, involve chest pain or fainting, include repeated vomiting or dehydration, suggest allergic reaction, or involve a possible dosing or storage error.
Detailed Reader Scenarios
A stronger page for does compounded tirzepatide expire needs to answer the situations people actually bring to search. The same keyword can represent a careful planner, someone with active symptoms, someone whose pharmacy instructions are confusing, or someone who is trying to decide whether the issue is urgent. The sections below turn the topic into practical scenarios without replacing medical judgment.
Scenario 1: The label and the internet disagree
Use the label and pharmacy instructions first. Internet articles often summarize branded storage rules, but compounded products, punctured vials, mailed medication, prefilled syringes, and pens can all have different requirements. If the product was exposed to heat, freezing, light, contamination risk, or an expired beyond-use date, the safest next step is to ask the pharmacy that dispensed it.
Scenario 2: The product looks normal
A normal appearance does not prove potency or sterility. Peptide medications can lose reliability without obvious color change. Appearance is still useful, but it is only one checkpoint. Cloudiness, particles, discoloration, damaged packaging, leakage, or a missing label should stop use until the pharmacy reviews it.
Scenario 3: The dose is due now
Do not let dose-day pressure force a guess. If a storage accident happens on injection day, call the pharmacy or prescriber and ask whether to use, replace, delay, or document the dose as missed. For diabetes patients, ask whether glucose monitoring should change while waiting for replacement.
Scenario 4: Travel or shipping caused the problem
Record the delivery time, ice-pack condition, vial temperature if known, package damage, and how long the medication sat outside. Many pharmacies need those details before replacing a product or judging whether a temperature excursion is acceptable.
Safe Handling Checklist
| Checkpoint | Use it only if... | Stop and ask if... |
|---|---|---|
| Date | Expiration or BUD is still valid | Date is expired, missing, or unreadable |
| Temperature | Exposure stayed inside written limits | It was hot, frozen, or unknown |
| Appearance | Clear and expected for that product | Cloudy, particles, color change, leakage |
| Container | Original labeled container | Unlabeled syringe, damaged vial, loose needle |
| Instructions | Pharmacy directions are clear | Advice conflicts or source is not the dispenser |
Why This Matters
The risk is not only reduced effectiveness. With compounded or transferred medication, sterility and handling can matter too. A dose that is weaker than expected can affect blood sugar or weight treatment. A contaminated or mishandled product can create injection-site or infection concerns. The practical answer is to preserve the product details, avoid guessing, and get a yes-or-no answer from the pharmacy.
Summary
Compounded tirzepatide expiration is pharmacy-specific. The BUD, storage history, and vial condition decide whether it should be used. The BUD itself is capped by USP <797> according to how the preparation was made — from 4 days refrigerated for an aseptically processed preparation with a nonsterile starting component and no sterility testing, up to 90 days refrigerated under full Category 3 compliance — and a multiple-dose vial is finished 28 days after its first puncture regardless of what the BUD says. Branded Zepbound and Mounjaro run on different rules entirely: 21 days at room temperature for a single-dose pen or vial, and 30 days after first use for a multi-dose vial. Do not borrow one product's numbers for another.
References
- USP <797> stability and beyond-use dating for compounded sterile preparations (PubMed)
- Compounding and the FDA: Questions and Answers (compounded drugs are not FDA-approved), U.S. FDA
- MOUNJARO (tirzepatide) injection — Prescribing Information (storage instructions), U.S. FDA
- USP General Chapter <797> Pharmaceutical Compounding — Sterile Preparations (Category 1/2/3 beyond-use date limits, Tables 13 and 14), U.S. Pharmacopeia
- USP <797> Frequently Asked Questions, updated December 11, 2023 (BUD versus in-use time; the 28-day limit after first puncture of a multiple-dose preparation), U.S. Pharmacopeia
- ZEPBOUND (tirzepatide) injection — full prescribing information, section 16.2 Storage and Handling, DailyMed/NLM
- Compounding and the FDA: Questions and Answers (503A vs 503B quality standards), U.S. FDA







